|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Three independent yearly analyses of the spectrum and potency of metronidazole : a multicenter study of 1, 108 contemporary anaerobic clinical isolates 显示文摘 | Erwin ME Fix AM Jones RN | 2001 | Diagn Microbiol Infect Dis2001，39，2： | 1 |
| 2 | Inhibition of Janus kinase3 and calcineurindependent signaling pathways synergistically prolongs the survival of rat heart allografts 显示文摘 | Behbod F Erwin - Cohen RA Wang ME | 2001 | J Immunol2001，166，6： | 1 |
| 3 | Comparative antimicrobial activity of gatifloxacin tested against campylobacter jejuni including fluoroquinolone-resistant clinical isolates显示文摘 | Erwin ME Barrett MS | 1999 | Diagn Microbiol Infect Dis1999，34，2： | 1 |
| 4 | Interlaboratory evaluation of E test method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose 显示文摘 | Espinel-Ingroff A Pfaller M Erwin ME | 1996 | J Clin Microbiol1996，34，： | 1 |
| 5 | In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated ox- azolidinones显示文摘 | Jones RN Johnson DM Erwin ME | 1996 | Antimicrob Agents Chemother1996，40，3： | 1 |
| 6 | Interlaboratory evaluation of Etest method for testing antifungal susceptilities of pathogenic yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose 显示文摘 | Espinel-Ingroff A M Pfaller Erwin ME | 1996 | J Clin Microbiol1996，34，： | 1 |
| 7 | Three independent yearly analyses of the spectrum and potency of metronidazole : a multicenter study of 1108 contemporary anaerobic clinical isolates显示文摘 | Erwin ME Fix AM Jones RN | 2001 | Diagn Microbiol Infect Dis2001，39，： | 1 |
| 8 | Interlaboratory evaluation of E-test method for testing antifungal susceptibilities of pathogenic Yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose显示文摘 | Espinel-Ingroff A Pfaller M Erwin ME | 1996 | J Clin Microbiol1996，34，： | 1 |
| 9 | In vitro activity and spectrum of LY333328, a novel glycopeptide derivative显示文摘 | JONES RN BARRETr MS ERWIN ME | 1997 | Antimicrob Agents Chemother1997，41，2： | 1 |
| 10 | Three independent yearly analyses of the spectrum and potency of metronidazole:a multicenter study of 1 108 contemporary anaerobic clinical isolates显示文摘 | Erwin ME Fix AM Jones RN | 2001 | Diagn Microbiol Infect Dis2001，39，： | 1 |
| 11 | Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards Susceptibility Testing Methods 显示文摘 | Worth S Erwin ME Jones RN | 1996 | Diagn Microbiol Infect Dis1996，24，： | 1 |
| 12 | In vitro antimicrobial activities and spectra of U-100592 and U-100766,two novel fluorinated oxazolidinones显示文摘 | Jones RN Johnson DM Erwin ME | 1996 | Antimicrob Agents Chemother1996，40，3： | 1 |
| 13 | Three independent yearly analyses of the spectrum and potency of metronidazole:a multicenter study of 1,108 contemporary anaerobic clinical isolates显示文摘 | Erwin ME Fix AM Jones RN | 2001 | Diagn Microbiol Infect Dis2001，39，2： | 1 |
| 14 | Comparative antimicrobia l activity of gatifloxacin tested against campylobacter jejuni including fluoroq uinolone resistant clinical isolates显示文摘 | HAYWARD CL ERWIN ME BARRETT MS | 1999 | Diagn Microbiol Infect Dis1999，34，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员